Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer — Stella

Home/Breast Cancer/Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

University Hospital Ulm Gynecology/Obstetrics, Ulm

Key details

Sponsor

Prof. Wolfgang Janni

Collaborators

German Federal Ministry of Education and Research

Enrollment target

~3,500 participants

Started

December 2022

Primary completion

December 2035

Age range

18 Years – 75 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.